ÃÛÌÒAPP

Skip to main content

CWRU spinout Convelo Therapeutics Inc. participating in bracket-style competition

Please note: Items that appear in the Community Postings section are submitted by visitors. Posts are reviewed to ensure they are appropriate for our audience, but typically are not edited by University Marketing and Communications.

The Cleveland Business Journal is hosting a bracket-style contest for innovative Cleveland businesses. Among the 16 companies is , a ÃÛÌÒAPP spinout based on research by Paul Tesar, the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics, and Drew Adams, associate professor of genetics and genome sciences.

The company’s focus is on creating regenerative medicine for neurological disorders.

Convelo Therapeutics is up against Cleveland Kitchen in the first round of voting, which continues through March 12.

EXPLORE MORE:
Community Postings